These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 610753)

  • 1. [Circadian variations in the plasma GH response to stimulation with L-dopa in normal women].
    Bellastella A; D'Alessandro B; Esposito V; De Luca R; Officioso A
    Boll Soc Ital Biol Sper; 1977 Dec; 53(23):2329-32. PubMed ID: 610753
    [No Abstract]   [Full Text] [Related]  

  • 2. [Circadian variations in the plasma GH response to L-dopa stimulation in female obesity].
    D'Alessandro B; Bellastella A; Cafaro MR; De Luca R; Esposito V
    Boll Soc Ital Biol Sper; 1977 Dec; 53(23):2333-6. PubMed ID: 610754
    [No Abstract]   [Full Text] [Related]  

  • 3. Growth hormone response to L-dopa in the thinned obese.
    Laurian L; Oberman Z; Hoerer E; Wiznitzer T; Harell A
    Isr J Med Sci; 1982 May; 18(5):625-9. PubMed ID: 7096047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone response in very short children.
    Palayew K; Crock P; Pianosi P; Coates A; Weitzner G; Schiffrin A
    Clin Invest Med; 1991 Aug; 14(4):331-7. PubMed ID: 1782731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Responses of growth hormone and prolactin to L-Dopa in women with polycystic ovarian syndrome].
    Wu X; Gu Q; Su Y
    Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):489-91. PubMed ID: 9639745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished growth hormone secretion in blind males after L-dopa stimulation.
    Fatranská M; Jurcovicová J; Németh S; Vigas M
    Endocrinol Exp; 1988 Dec; 22(4):243-8. PubMed ID: 3243205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal growth hormone responsiveness to stimuli in women with active celiac sprue.
    Peracchi M; Molteni N; Cantalamessa L; Bardella MT; Peracchi G; Orsatti A; Faggioli P; Bianchi PA
    Am J Gastroenterol; 1992 May; 87(5):580-3. PubMed ID: 1595643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma prolactin and GH response after thyrotropin-releasing hormone (TRH), L-DOPA and sulpiride in patients with senile dementia of Alzheimer type].
    Fujita M; Toyoda K; Motomura N; Kuroda K; Shimizu T
    Rinsho Shinkeigaku; 1985 Jul; 25(7):767-75. PubMed ID: 3935351
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
    Esel E; Kartalci S; Tutus A; Turan T; Sofuoglu S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone refractory interval to levodopa stimulation.
    Parker KM; Eddy RL
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1188-91. PubMed ID: 932184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP; Christensen SE; Lundbaek K
    Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Circadian rhythms in the plasma GH in normal and obese women].
    Esposito V; Bellastella A; D'Alessandro B; Fratellanza A; Iaccarino P; Iacono G
    Boll Soc Ital Biol Sper; 1977 Dec; 53(23):2325-8. PubMed ID: 610752
    [No Abstract]   [Full Text] [Related]  

  • 13. Propranolol enhancement of L-DOPA induced growth hormone stimulation.
    Camanni F; Massara F; Molinatti GM
    Biomedicine; 1974 Jun; 21(6):241-3. PubMed ID: 4441586
    [No Abstract]   [Full Text] [Related]  

  • 14. Circadian variation in neuroendocrine response to L-dopa in patients with restless legs syndrome.
    Garcia-Borreguero D; Larrosa O; Granizo JJ; de la Llave Y; Hening WA
    Sleep; 2004 Jun; 27(4):669-73. PubMed ID: 15283001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations].
    De Marinis L; Mancini A; Zuppi P; Fiumara C; Iacona T; Conte G; Fabrizi ML; Valle D; Anile C; Maira G
    Minerva Chir; 1993 Nov; 48(21-22):1337-40. PubMed ID: 8152567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Attempt at potentiation of the action of L-dopa on the secretion of growth hormone by benserazide, disulfiram and propranolol].
    Rochiccioli P; Enjaume P; Dutau G; Ribot C; Augier D
    Arch Fr Pediatr; 1976 Jan; 33(1):55-66. PubMed ID: 985031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous diurnal variations of serum prolactin and prolactin response to L-dopa in man. Effect of cyproheptadine.
    Delitala G; Masala A; Alagna S; Rovasio PP; Devilla L
    IRCS J Med Sci; 1975 Apr; 3(4):199. PubMed ID: 1172495
    [No Abstract]   [Full Text] [Related]  

  • 18. High growth hormone levels in clinically short stature children.
    Awan TM; Sattar A; Khattak IG
    J Ayub Med Coll Abbottabad; 2006; 18(2):29-33. PubMed ID: 16977810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian and ultradian characteristics of plasma growth hormone in children with normal and short stature.
    Hermida RC; Garcia L; Lodeiro C; Ayala DE; Iglesias T; Halberg F
    J Endocrinol Invest; 1989; 12(8 Suppl 3):69-73. PubMed ID: 2509542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differential diagnosis of growth disorders based on the determination of growth hormone secretion following administration of L-dopa].
    Gembicki M; Kosowicz J; Sobieszczyk S
    Pol Arch Med Wewn; 1975 Aug; 54(2):147-52. PubMed ID: 1161535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.